Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $930.67 Analyst target: $869.07 Upside: -6.62%
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
See the full interactive analysis & chart →Informational only — not investment advice.